Medication-Assisted Treatment

Taking a medication to get clean can feel like cheating. It isn't. For opioid and alcohol addiction, MAT pairs medicine with counseling, and it is the treatment most likely to keep you alive and in recovery.

Jessica Miller is the Content Manager of Addiction HelpWritten by
Kent S. Hoffman, D.O. is a founder of Addiction HelpMedically reviewed by Kent S. Hoffman, D.O.
Last updated

Battling addiction & ready for help?

Find Treatment Now

What Medication-Assisted Treatment Is

Medication-assisted treatment, or MAT, is addiction care that uses a prescription medication alongside counseling and behavioral therapy to treat a substance use disorder. It is two things working together: a medicine that steadies the brain and body, and the therapy that helps you rebuild a life. For opioid addiction the same approach is often called MOUD — medication for opioid use disorder — and across the board you will hear it called pharmacotherapy. Different names, one idea: medicine plus support, not medicine instead of it.

The medicine is not a shortcut around the work of recovery. It is what makes the work possible. Cravings that once ran the whole day quiet down. The fog of withdrawal lifts. With the constant physical pull turned down, a person finally has room to use the rest of treatment — therapy, relapse-prevention skills, a steadier daily life — instead of spending every waking hour managing the urge to use.

If you are weighing this for yourself or someone you love and wondering whether taking a medication still counts as getting clean, that question is worth sitting with, and it has a clear answer. This is evidence-based medicine, and for opioid addiction it is the standard of care. The way through is more bearable than the fear of it, and medication is a large part of why.

AddictionHelp.com Fast Facts
  • MAT pairs a medication with counseling — and the pairing is the point: combining behavioral therapy with medication is considered best practice for addiction, and the two together outperform either piece on its own[1].
  • For opioid use disorder, medication is the standard of care: opioid agonist treatment with buprenorphine or methadone is highly effective and improves a wide range of outcomes for people who receive it[2].
  • Staying in treatment is the whole game, and medication is what keeps people in it: buprenorphine and methadone both retain people in care far better than no medication, which is the foundation everything else is built on[3].
  • Alcohol addiction has effective medications too, and they are badly underused: approved medicines for alcohol use disorder meaningfully help people cut down or stay abstinent, yet only a small share of people who could benefit ever receive one[4].
  • You can start without leaving your life behind: buprenorphine and naltrexone are often prescribed in an ordinary doctor’s office or by telehealth, and emergency-department-initiated buprenorphine improves outcomes for people in crisis[5].

How the Medications Work, in Plain Language

Agonist, partial agonist, antagonistThe whole map fits in one line. An agonist satisfies the receptor (methadone), a partial agonist satisfies it part way with a safety ceiling (buprenorphine), and an antagonist blocks it so the drug does nothing (naltrexone). Same target, three different jobs.

Most MAT medications act on the same brain receptors a drug does — but on purpose, at a controlled dose, to take away the chaos rather than feed it. Three plain categories cover almost everything, and the difference between them is mostly how hard they push on the receptor.

An agonist fully activates the receptor. Methadone is the example for opioids. Given once a day under medical oversight, it occupies the opioid receptors steadily, so withdrawal and craving fade without the roller coaster of getting high and crashing. The receptor is satisfied; the person is not impaired.

A partial agonist activates the receptor too, but only part way, with a built-in ceiling. Buprenorphine works like this. It is strong enough to stop withdrawal and craving, yet it flattens out past a certain dose, which makes it safer in overdose terms than a full agonist and a reason it can be prescribed in an office rather than a clinic.

An antagonist blocks the receptor entirely. Naltrexone is the example, used for both opioid and alcohol addiction. It is not opioid-based and is not habit-forming. It sits on the receptor and shuts the door, so opioids cannot produce a high and alcohol loses much of its pull. There is nothing to taper off when the time comes.

None of these is the addiction wearing a lab coat. A steady medication that removes craving without a high is the opposite of the cycle it replaces — and which one fits depends on the substance, your history, and your goals, which is a conversation to have with a clinician, not a decision to make alone.

The MAT Medications at a Glance

Here are the core medications in one view, grouped by what they treat, with a link to the full write-up on each. Most are FDA-approved for exactly this use; a clinician matches the one that fits your situation.

Medication How it works For which addiction Learn more
Buprenorphine Partial agonist — eases withdrawal and craving with a built-in safety ceiling; often office-based Opioid use disorder Buprenorphine for opioid addiction →
Suboxone (buprenorphine + naloxone) The most common buprenorphine formulation; naloxone is added to deter misuse Opioid use disorder How Suboxone works →
Methadone Full agonist — fully steadies the opioid receptors at a controlled daily dose; given through an opioid treatment program Opioid use disorder Methadone explained →
Naltrexone Antagonist — blocks the receptor so opioids and alcohol lose their effect; not habit-forming Opioid and alcohol use disorder Naltrexone explained →
Vivitrol (extended-release naltrexone) A once-monthly naltrexone injection, so there is no daily pill to remember Opioid and alcohol use disorder About the Vivitrol shot →
Acamprosate Helps a brain rebalance after long-term drinking, easing protracted withdrawal Alcohol use disorder The medication options for addiction →
Disulfiram Causes an unpleasant reaction if you drink, as a deterrent for the right, motivated person Alcohol use disorder The medication options for addiction →

Not sure how two of these compare? See buprenorphine and methadone side by side →

The Medications for Opioid Use Disorder

Three medications, one goalBuprenorphine and methadone steady the receptor so craving fades; naltrexone blocks it so the drug does nothing. All three aim at the same finish line — a life that is no longer organized around the next dose — and the right pick depends on the person, not a ranking.

For opioid addiction, three medications carry the load: buprenorphine, methadone, and naltrexone. This is the part of MAT with the deepest evidence behind it, and it is why the approach is the recognized standard of care rather than one option among many.

Buprenorphine is the partial agonist most people start with today. It quiets withdrawal and craving, its safety ceiling lowers overdose risk compared with a full agonist, and crucially it can be prescribed in an ordinary medical office or by telehealth instead of requiring a daily clinic visit. Compared head to head with methadone, buprenorphine performs similarly on the outcomes that matter most, including keeping people in treatment[3]. It is most often given as Suboxone, a combination with naloxone that discourages misuse. The medicine even works when started in a crisis: buprenorphine begun in the emergency department leads to better outcomes than a brief talk and a referral[5].

Methadone is the full agonist, and for many people it is the one that finally works. Taken once a day through a licensed opioid treatment program, it fully steadies the opioid receptors so the day stops revolving around the next dose. Methadone and buprenorphine are the two pillars of opioid agonist treatment, and across a wide range of outcomes both substantially outperform no medication at all[2]. The structure of a daily program is not a downside for everyone — for some, the routine and the on-site counseling are part of what holds recovery together.

Naltrexone takes the opposite approach: it blocks instead of satisfies. Because it is an antagonist, opioids simply cannot produce a high while it is on board, and because it is not opioid-based it carries no dependence of its own. It works best once a person is already through withdrawal, and the monthly injectable form, Vivitrol, removes the daily decision to take a pill. Extended-release naltrexone is associated with better treatment persistence than the oral version[6], and the injectable form is especially useful where a daily agonist is hard to access, such as for people leaving the justice system[7].

Did you know?

The choice is not only about the person in front of the clinician. In pregnancy, both methadone and buprenorphine are recommended over continued illicit opioid use, and the research comparing the two guides care for parent and baby together rather than forcing an either/or[8]. Opioid addiction touches more than one life, and the medications are studied with that in mind.

The Medications for Alcohol Use Disorder

Drinking has medicines too, and almost no one is offered themIf you have tried to stop drinking on willpower alone and it has not held, that is not a verdict on you. Effective medications exist, they meaningfully help, and most people who could benefit are never even told about them. Asking for one is not weakness — it is using the full toolkit.

Alcohol addiction has its own set of medications, and they are some of the most overlooked tools in all of medicine. Three are commonly used, and each works in a different way.

Naltrexone does double duty. The same receptor-blocker used for opioids also dampens the reward from drinking, which helps many people cut back or stop. It comes as a daily pill or as the monthly Vivitrol injection, and it is one of the better-supported options for alcohol use disorder[4]. For people whose drinking has already harmed the liver, medication for alcohol use disorder is linked to better abstinence even in those with cirrhosis[9].

Acamprosate helps a brain find its footing after long-term drinking. It works on the chemical imbalance that heavy alcohol use leaves behind, easing the drawn-out restlessness, poor sleep, and unease of early sobriety so that staying stopped feels less like a daily battle. It is one of the approved medicines shown to help people maintain abstinence[4].

Disulfiram works by deterrence rather than craving. It causes a deliberately unpleasant reaction if a person drinks, which for a motivated person can be the wall that stops a slip before it starts. It is not the right tool for everyone, but for the right person it has a real place. How well any of these medications work also depends on how severe the addiction is, which is part of why the choice is individual rather than one-size-fits-all[10].

The Evidence: Why MAT Is the Standard of Care

MAT is not replacing one drug with anotherThis is the myth worth dismantling gently. A controlled medication that erases craving and lets someone hold a job, repair a family, and stay alive is the opposite of an addiction — addiction is chaos and loss of control; this is stability and a life back. Calling it “just another drug” has kept people from a treatment that could have saved them. It is medicine, the same as insulin or blood-pressure pills, and it works.

The case for MAT is not a matter of opinion. For opioid use disorder, medication is the most effective treatment there is, and the evidence is unusually consistent. Opioid agonist treatment with buprenorphine or methadone improves a broad range of outcomes for the people who receive it[2], and the umbrella of high-quality reviews behind buprenorphine, methadone, and naltrexone is what places these medications at the center of care[11].

The single most important thing medication does is keep people in treatment, because a person who stays in care is a person who is still alive and still has a shot. Both buprenorphine and methadone retain people far better than no medication does[3], and retention is the platform on which every other gain — fewer relapses, a steadier life, recovered relationships — is built.

Medication does not replace counseling; it makes counseling land. Combined behavioral therapy and medication is the recognized best practice for addiction, with the pairing more effective than either alone[1]. On top of that base, added behavioral tools help further: contingency management, which rewards verified progress, improves outcomes for people already on medication for opioid use disorder[12], and psychosocial support layered onto methadone maintenance adds real benefit[13].

The Stigma That Keeps People From a Treatment That Works

A fair question to bring to any programYou are allowed to ask a treatment provider where they stand: do you offer medication for opioid or alcohol use disorder, and do you support staying on it as long as it helps? A program that treats medication as a normal, evidence-based part of care is a program that has read the evidence.

There is a stubborn idea out there that taking buprenorphine or methadone is not “real” recovery — that it is just trading one drug for another, that a person on medication has not truly quit. It sounds intuitive. It is also wrong, and it has done real harm.

Here is the difference the myth misses. Addiction is the loss of control: using more than intended, in spite of the wreckage, unable to stop. A prescribed medication taken as directed produces none of that. It does not get a person high, it does not escalate, and it hands back the very control that addiction stole. Someone steadied on medication can work, parent, drive, and show up — the markers of a life reclaimed, not a habit relabeled.

The cost of the stigma is not abstract. When people, and sometimes the programs meant to help them, treat medication as a moral compromise, fewer people start it and more people leave it early — and leaving early is exactly when the danger of relapse and overdose climbs back up. Framing the most effective treatment for opioid addiction as a half-measure is not caution. It is a barrier between a person and the thing most likely to keep them alive.

So if you are afraid that choosing medication means you did not really do the work, set that fear down. The work is staying alive, staying in treatment, and rebuilding — and medication is what makes all three more likely. This is real recovery. It is, for many people, the only version that has ever held.

Access: It Works, So Why Is It So Underused?

Underused does not mean unavailableIf the first program you reach does not offer medication, that is a reason to keep dialing, not to give up on the idea. The treatment exists and it works; the only question is finding the door that has it open.

Here is the frustrating gap at the heart of MAT. The treatment is effective, it is recommended, and most people who could benefit never get it. For alcohol use disorder the approved medications help, yet only a small fraction of eligible people are ever prescribed one[4]. For opioid use disorder, the medications are the standard of care and still far from universally offered.

Not every program provides it, which means it is worth asking for by name. Some treatment centers are built around medication; others still lean abstinence-only and may not offer it at all. That is not a reason to settle. Walk in knowing the words — medication-assisted treatment, MAT, MOUD, buprenorphine, methadone, naltrexone — and ask directly. If a program does not provide the medication you need, that is information about the program, not about whether you deserve the treatment, and you can keep looking until a provider says yes.

The shape of access is also genuinely better than it used to be. Buprenorphine and naltrexone are increasingly prescribed in regular doctors’ offices and through telehealth, and buprenorphine can even be started in an emergency room during a crisis[5]. The door is wider than the old picture of MAT suggests.

How to Start MAT and Find a Provider

The path in is more straightforward than the fear of it makes it look, and it splits along simple lines depending on the medication.

Methadone runs through an opioid treatment program. Because it is a full agonist, it is dispensed by federally licensed clinics — opioid treatment programs — usually with counseling on site and daily or near-daily visits at first that ease over time as you stabilize. Finding the nearest program is the first step, and a directory makes that quick. Find a treatment provider near you →

Buprenorphine and naltrexone are often far easier to begin. Both can be prescribed by a wide and growing range of clinicians — in primary care, in addiction medicine, and increasingly over telehealth — so for many people starting buprenorphine or naltrexone looks like a doctor’s appointment, not a move into a clinic. If your current doctor does not prescribe it, they can refer you, or you can search for one who does. Search treatment centers and providers →

If you are not yet sure which medication or which setting fits, that is normal, and you do not have to figure it out by yourself. Matching the right medication and the right level of support is exactly what an intake clinician does. Get help finding the right treatment → · Compare the levels of addiction care → · Explore the full range of drug rehab options →

MAT is medicine that works, for a problem that has good answers. The craving can quiet, the danger can drop, and the life on the other side is steadier than the one addiction offered — and the way there is more bearable than the fear of starting usually makes it seem. This is something you can begin, and you do not have to begin it alone.

The next step doesn’t have to be a big one. You can find treatment now and get matched with someone who can help you find the right care and take the next step. Reaching out today is a real step forward — and one you can make right now.

Frequently asked questions

What is medication-assisted treatment (MAT)?

Medication-assisted treatment, or MAT, is addiction care that combines a prescription medication with counseling and behavioral therapy to treat a substance use disorder. For opioid addiction it is often called MOUD (medication for opioid use disorder), and you will also hear it called pharmacotherapy. The medication steadies the brain and body by easing cravings and withdrawal, which frees a person to use the rest of treatment instead of fighting the urge to use all day. The pairing is the point: combining behavioral therapy with medication is considered best practice for addiction, and the two together work better than either alone[1].

What medications are used in MAT?

For opioid use disorder, the three core medications are buprenorphine (a partial agonist that eases withdrawal with a safety ceiling, often given as Suboxone), methadone (a full agonist dispensed through a licensed opioid treatment program), and naltrexone (an antagonist that blocks the receptor so opioids produce no high, also available as the monthly Vivitrol injection). For alcohol use disorder, the common medications are naltrexone (which also dampens the reward from drinking), acamprosate (which helps a brain rebalance after long-term drinking), and disulfiram (which deters drinking by causing an unpleasant reaction). The reviews behind buprenorphine, methadone, and naltrexone are what place them at the center of opioid care[11].

Is MAT just replacing one drug with another?

No. This is one of the most damaging myths in addiction care. Addiction is the loss of control — using more than intended, despite the harm, unable to stop. A prescribed medication taken as directed does the opposite: it does not get a person high, it does not escalate, and it hands back the control addiction took, so someone can work, parent, and stay alive. A controlled medication that erases craving and lets a person rebuild a life is not an addiction relabeled; it is medicine, the same as insulin or blood-pressure pills. Treating it as a moral compromise keeps people from the very treatment most likely to keep them alive, because leaving medication early is exactly when relapse risk climbs[3].

Does MAT actually work?

Yes, and for opioid use disorder it is the most effective treatment there is — the recognized standard of care. Opioid agonist treatment with buprenorphine or methadone improves a broad range of outcomes for the people who receive it[2]. The single most important thing it does is keep people in treatment, and both buprenorphine and methadone retain people far better than no medication does, which is the platform every other gain is built on[3]. Medication does not replace counseling — it makes counseling land, since the combination of behavioral therapy and medication is best practice and outperforms either alone[1]. For alcohol use disorder, approved medications also meaningfully help people cut down or stay abstinent[4].

How do I find MAT or a clinic?

It depends on the medication. Methadone is dispensed through federally licensed opioid treatment programs — clinics that usually include on-site counseling — so the first step is finding the nearest one. Buprenorphine and naltrexone are often far easier to start: both can be prescribed in primary care, in addiction medicine, and increasingly over telehealth, so beginning treatment can look like a regular doctor’s appointment rather than a move into a clinic. Buprenorphine can even be started in an emergency room during a crisis, which improves outcomes[5]. If you are not sure which medication or setting fits, an intake clinician can match you. You can search providers and clinics at /treatment-centers/ or get help matching at /find-treatment-help/.

Is MAT different for alcohol than for opioids?

The principle is the same — medication plus counseling — but the medications differ. Opioid use disorder is treated with buprenorphine, methadone, or naltrexone, and medication is the standard of care with unusually strong evidence behind it[2]. Alcohol use disorder is treated with naltrexone, acamprosate, or disulfiram; these are effective and help people cut down or stay abstinent, but they are badly underused, with only a small share of eligible people ever prescribed one[4]. Naltrexone is notable for working on both: the same receptor-blocker dampens the reward from opioids and from alcohol. Which medication fits depends on the substance, your history, and how severe the addiction is, which is why the choice is individual rather than one-size-fits-all[10].

Get Treatment Help

If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.

Exclusive offer: 20% Off BetterHelp*

Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.

13 Sources
  1. Ray LA, Meredith LR, Kiluk BD, Walthers J, Carroll KM, Magill M (2020). Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders: A Systematic Review and Meta-analysis. JAMA network open. https://doi.org/10.1111/add.14289
  2. Degenhardt L, Clark B, Macpherson G, Leppan O, Nielsen S, Zahra E, et al. (2023). Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies. The lancet. Psychiatry. https://doi.org/10.1016/s2215-0366(23)00095-0
  3. Pereira da Silva AM, de Bastos Maximiano ML, Cabeça LS, Leal Silva L, Honorato de Faria E, Nepomuceno Fernandes M, et al. (2025). Buprenorphine-naloxone vs methadone for opioid use disorder: a systematic review and meta-analysis of randomized clinical trials. Journal of addictive diseases. https://doi.org/10.1080/10550887.2025.2514308
  4. McPheeters M, O'Connor EA, Riley S, Kennedy SM, Voisin C, Kuznacic K, et al. (2023). Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis. JAMA. https://doi.org/10.1093/alcalc/agm136
  5. Bavali-Gazik A, Hosseini SN, Salehian S, Kadkhoda M, Salari A, Akhavan-Abdollahian A (2026). Emergency department-initiated buprenorphine vs brief intervention for opioid use disorder: a systematic review and meta-analysis of clinical trials. Journal of addictive diseases. https://doi.org/10.1080/10550887.2025.2605451
  6. Elmosalamy A, Sirohi A, Moustafa A, Masoud O, Hassett LC, Kolla BP, et al. (2025). Extended-release naltrexone versus oral naltrexone for substance use disorders: A systematic review and meta-analysis. Drug Alcohol Depend. https://doi.org/10.1016/j.drugalcdep.2025.112789
  7. Bahji A, Carlone D, Altomare J (2020). Acceptability and efficacy of naltrexone for criminal justice-involved individuals with opioid use disorder: a systematic review and meta-analysis. Addiction (Abingdon, England). https://doi.org/10.1111/add.14946
  8. Kinsella M, Halliday LOE, Shaw M, Capel Y, Nelson SM, Kearns RJ (2022). Buprenorphine Compared with Methadone in Pregnancy: A Systematic Review and Meta-Analysis. Substance use & misuse. https://doi.org/10.1080/10826084.2022.2083174
  9. Gratacós-Ginès J, Bruguera P, Pérez-Guasch M, López-Lazcano A, Borràs R, Hernández-Évole H, et al. (2024). Medications for alcohol use disorder promote abstinence in alcohol-associated cirrhosis: Results from a systematic review and meta-analysis. Hepatology (Baltimore, Md.). https://doi.org/10.1097/HEP.0000000000000570
  10. Agabio R, Lopez-Pelayo H, Bruguera P, Huang S, Sardo S, Pecina M, et al. (2024). Efficacy of medications for the treatment of alcohol use disorder (AUD): A systematic review and meta-analysis considering baseline AUD severity. Pharmacol Res. https://doi.org/10.1016/j.phrs.2024.107454
  11. Korownyk C, Perry D, Ton J, Kolber MR, Garrison S, Thomas B, et al. (2019). Opioid use disorder in primary care: PEER umbrella systematic review of systematic reviews. Canadian family physician Medecin de famille canadien.
  12. Bolívar HA, Klemperer EM, Coleman SRM, DeSarno M, Skelly JM, Higgins ST (2021). Contingency Management for Patients Receiving Medication for Opioid Use Disorder: A Systematic Review and Meta-analysis. JAMA psychiatry. https://doi.org/10.1001/jamapsychiatry.2021.1969
  13. Wen H, Xiang X, Jiang Y, Zhang H, Zhang P, Chen R, et al. (2023). Comparative efficacy of psychosocial interventions for opioid-dependent people receiving methadone maintenance treatment: A network meta-analysis. Addiction (Abingdon, England). https://doi.org/10.1111/add.16167
Written by
Jessica Miller is the Content Manager of Addiction Help

Editorial Director

Jessica Miller is the Editorial Director of Addiction Help. Jessica graduated from the University of South Florida (USF) with an English degree and combines her writing expertise and passion for helping others to deliver reliable information to those impacted by addiction. Informed by her personal journey to recovery and support of loved ones in sobriety, Jessica's empathetic and authentic approach resonates deeply with the Addiction Help community.

Reviewed by
  • Fact-Checked
  • Editor
Kent S. Hoffman, D.O. is a founder of Addiction Help

Co-Founder & Chief Medical Officer

Kent S. Hoffman, D.O. has been an expert in addiction medicine for more than 15 years. In addition to managing a successful family medical practice, Dr. Hoffman is board certified in addiction medicine by the American Osteopathic Academy of Addiction Medicine (AOAAM). Dr. Hoffman has successfully treated hundreds of patients battling addiction. Dr. Hoffman is the Co-Founder and Chief Medical Officer of AddictionHelp.com and ensures the website’s medical content and messaging quality.

Real Help. Real Recovery.

Compare centers, explore options and start your path to recovery today.

Find Treatment Now

"AddictionHelp.com is helping to make recovery available to EVERYONE!"

- Angela N.